Practice Area: 
Stock Symbol: 
Case Status: 
Recent Cases
Class Period: 
June 4, 2018 to September 25, 2018
Motion Deadline: 
October 8, 2018

Ademi & O’Reilly, LLP announces that a class action lawsuit has been filed against TG Therapeutics, Inc. on behalf of investors who purchased shares between June 4, 2018 and September 25, 2018.

The lawsuit alleges that TG Therapeutics made false and misleading statements about its UNITY-CLL Trial and the potential commercialization of novel treatments for B-cell malignancies and autoimmune diseases.  As a result of these false and misleading statements, the price of TG Therapeutics common stock was inflated to as high as $14.70 per share before falling 44% on September 25, 2018, from $9.25 per share to $5.15 per share.